HeyJaredThe Shkreli Pill
The only pill worth swallowing. Markets, memes, medicine, and mayhem — served straight, no chaser.Watch the video versions on YouTube: https://www.youtube.com/@TheShkreliPill/videos.
- Indexed episodes, last 90 days
- 138
- Latest publication
- Sep 8, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 28, 2026
Latest episodes
Episode 1034: Martin Shkreli Says We Are In A Simulation & Religion Is Made Up (opens the original)
Read excerpt
In this episode, Martin discusses his views on simulation theory, religion, and the nature of reality. He explores philosophical questions surrounding consciousness, existence, belief, and whether reality could be simulated, while explaining his skepticism toward religious claims and debating different perspectives on faith, science, and how people make sense of the world.
Episode 1033: Trading Is Dead： Real Money Isn’t Made by Being Right (opens the original)
Read excerpt
In this episode, Martin challenges the idea that successful investing is simply about correctly predicting which direction a stock will move. He discusses why having an edge, properly sizing positions, managing risk, and allocating capital efficiently can matter more than being right on individual trades. The episode explores expected value, probabilities, portfolio construction, and how investors can turn small advantages into meaningful long-term returns.
Episode 1032: Martin Shkreli Fights Antisemitism In His Chat (opens the original)
Read excerpt
In this episode, Martin confronts antisemitic comments appearing in his chat and challenges the arguments and stereotypes behind them. He discusses the importance of rejecting prejudice and discrimination while responding directly to members of the audience, examining how misinformation, inflammatory rhetoric, and harmful generalizations can spread through online communities.
Episode 1031: Oracle’s Biggest Risk Isn’t Credit. SanDisk a Valuation Time Bomb, Intel Stock, RARE (opens the original)
Read excerpt
In this episode, Martin examines Oracle and explains why he believes the company’s biggest risk extends beyond concerns about credit and financing. He also revisits his bearish thesis on SanDisk, arguing that its valuation could leave the stock vulnerable if memory-market expectations weaken. Martin then discusses Intel and analyzes Ultragenyx (RARE), examining their valuations, competitive positions, catalysts, and the key risks shaping his current investment outlook.
Episode 1030: Robinhood： The Short Nobody Sees, Korean Tariff Threat to Chip Stocks, Dell Stock (opens the original)
Read excerpt
In this episode, Martin lays out his bearish thesis on Robinhood and explains why he believes the market may be overlooking important risks to the company’s valuation and growth expectations. He also discusses the potential impact of Korean tariff developments on semiconductor and memory stocks before analyzing Dell, examining its AI infrastructure exposure, competitive position, valuation, and the factors shaping his current investment outlook.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.